Prevalence of methylenetetrahydrofolate reductase mutations in patients with venous thrombosis
Data up to Jan 2025
Total Citations Per Year
Abstract
References (31)
A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease
1995 • 3,645 citations
Prevention of neural tube defects: Results of the Medical Research Council vitamin study
1992 • 2,294 citations
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
1991 • 2,191 citations
Plasma Homocysteine as a Risk Factor for Vascular Disease
1997 • 1,770 citations
Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.
1991 • 1,717 citations
A Second Common Mutation in the Methylenetetrahydrofolate Reductase Gene: An Additional Risk Factor for Neural-Tube Defects?
1998 • 1,569 citations
Relation Between Folate Status, a Common Mutation in Methylenetetrahydrofolate Reductase, and Plasma Homocysteine Concentrations
1996 • 1,423 citations
A Second Genetic Polymorphism in Methylenetetrahydrofolate Reductase (MTHFR) Associated with Decreased Enzyme Activity
1998 • 1,283 citations
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
1996 • 1,034 citations
Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
1995 • 870 citations
Homocysteine metabolism in pregnancies complicated by neural-tube defects
1995 • 641 citations
Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells
1990 • 392 citations
Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.
1986 • 390 citations
Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis?
1995 • 374 citations
Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss
1993 • 294 citations
Elevated homocyst(e)ine levels with preeclampsia
1997 • 193 citations
Thermolabile Methylenetetrahydrofolate Reductase and Factor V Leiden in the Risk of Deep-Vein Thrombosis
1998 • 160 citations
The Methylenetetrahydrofolate Reductase TT677 Genotype Is Associated with Venous Thrombosis Independently of the Coexistence of the FV Leiden and the Prothrombin
1998 • 141 citations
Clinical chemistry and molecular biology of homocysteine metabolism: An update
1997 • 135 citations
Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida [short report]
1995 • 93 citations
Oral Contraceptives and Thrombotic Disease: Risk of Venous Thromboembolism
1997 • 88 citations
Hyperhomocyst(e)inemia and Atherothrombosisa
1997 • 87 citations
High frequency (71%) of cystathionine β-synthase mutation G307S in Irish homocystinuria patients
1995 • 80 citations
Clinical Hematology: Principles, Procedures, Correlations
1992 • 73 citations
C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
1999 • 69 citations
Mutated 5,10-methylenetetrahydrofolate reductase and moderate hyperhomocysteinaemia
1998 • 41 citations
Hyperhomocysteinemia and venous thromboembolic disease.
1997 • 38 citations
The inherited basis of venous thrombosis
1997 • 32 citations
Risk of venous thrombosis in carriers of a common mutation in the homocysteine regulatory enzyme methylenetetrahydrofolate reductase*
1997 • 21 citations
Genetic determinants of heritable venous thrombosis: genotyping methods for factor VLEIDEN A1691G, methylenetetrahydrofolate reductase C677T, prothrombin G20210A mutation, and algorithms for venous thrombosis investigations
1999 • 13 citations
Non-fasting reference intervals for the Abbott IMxTM homocysteine and AxSYMTM plasma folate assays: influence of the methylenetetrahydrofolate reductase 677 C→T mutation on homocysteine
2000 • 9 citations